Vikas Sehdev

611 total citations
14 papers, 504 citations indexed

About

Vikas Sehdev is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Vikas Sehdev has authored 14 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Cell Biology. Recurrent topics in Vikas Sehdev's work include Cancer-related Molecular Pathways (7 papers), Microtubule and mitosis dynamics (4 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Vikas Sehdev is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Microtubule and mitosis dynamics (4 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Vikas Sehdev collaborates with scholars based in United States. Vikas Sehdev's co-authors include Abbes Belkhiri, Dunfa Peng, Wael El‐Rifai, Jeffrey Ecsedy, Alexander Zaika, James C. K. Lai, Alok Bhushan, Ahmed Katsha, Mohammed Soutto and Jun Hong and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer.

In The Last Decade

Vikas Sehdev

13 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vikas Sehdev United States 9 292 213 167 76 70 14 504
Rosaria Chilà Italy 15 433 1.5× 290 1.4× 72 0.4× 89 1.2× 111 1.6× 21 703
Anna M. Schläfli Switzerland 13 433 1.5× 77 0.4× 90 0.5× 63 0.8× 128 1.8× 17 668
Heba Alshaker United Kingdom 16 487 1.7× 149 0.7× 120 0.7× 110 1.4× 157 2.2× 24 733
Georges K. De Bruyne Belgium 11 429 1.5× 186 0.9× 114 0.7× 27 0.4× 64 0.9× 16 639
Mary E. Law United States 14 303 1.0× 188 0.9× 167 1.0× 71 0.9× 65 0.9× 22 514
Takeo Shimasaki Japan 13 479 1.6× 203 1.0× 50 0.3× 78 1.0× 123 1.8× 37 670
Melanie Rothley Germany 13 342 1.2× 126 0.6× 156 0.9× 49 0.6× 156 2.2× 20 618
Sathyen A. Prabhu United States 9 321 1.1× 94 0.4× 61 0.4× 57 0.8× 69 1.0× 12 454
Liqing Zhuang Australia 7 345 1.2× 200 0.9× 92 0.6× 93 1.2× 111 1.6× 7 535
Puxiongzhi Wang China 11 248 0.8× 276 1.3× 70 0.4× 100 1.3× 113 1.6× 15 542

Countries citing papers authored by Vikas Sehdev

Since Specialization
Citations

This map shows the geographic impact of Vikas Sehdev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikas Sehdev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikas Sehdev more than expected).

Fields of papers citing papers by Vikas Sehdev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikas Sehdev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikas Sehdev. The network helps show where Vikas Sehdev may publish in the future.

Co-authorship network of co-authors of Vikas Sehdev

This figure shows the co-authorship network connecting the top 25 collaborators of Vikas Sehdev. A scholar is included among the top collaborators of Vikas Sehdev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikas Sehdev. Vikas Sehdev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Dichwalkar, Tanmay, et al.. (2017). Omega‐3 Fatty Acid Grafted PAMAM‐Paclitaxel Conjugate Exhibits Enhanced Anticancer Activity in Upper Gastrointestinal Cancer Cells. Macromolecular Bioscience. 17(8). 23 indexed citations
2.
4.
Sehdev, Vikas. (2014). Selective Targeting of M3 Muscarinic Receptors: an Opportunity for Improved Treatment of Upper Gastrointestinal Carcinomas. Pharmacy & Pharmacology International Journal. 1(1). 2 indexed citations
5.
Sehdev, Vikas, Ahmed Katsha, Dunfa Peng, et al.. (2013). HDM2 Regulation by AURKA Promotes Cell Survival in Gastric Cancer. Clinical Cancer Research. 20(1). 76–86. 56 indexed citations
6.
Katsha, Ahmed, Mohammed Soutto, Vikas Sehdev, et al.. (2013). Aurora Kinase A Promotes Inflammation and Tumorigenesis in Mice and Human Gastric Neoplasia. Gastroenterology. 145(6). 1312–1322.e8. 91 indexed citations
7.
Bhardwaj, Vikas, Satya Murthy Tadinada, Aditi Jain, et al.. (2013). Biochanin A reduces pancreatic cancer survival and progression. Anti-Cancer Drugs. 25(3). 296–302. 35 indexed citations
9.
Hong, Jun, Dunfa Peng, Zheng Chen, Vikas Sehdev, & Abbes Belkhiri. (2012). ABL Regulation by AXL Promotes Cisplatin Resistance in Esophageal Cancer. Cancer Research. 73(1). 331–340. 69 indexed citations
10.
Sehdev, Vikas, Dunfa Peng, Mohammed Soutto, et al.. (2012). The Aurora Kinase A Inhibitor MLN8237 Enhances Cisplatin-Induced Cell Death in Esophageal Adenocarcinoma Cells. Molecular Cancer Therapeutics. 11(3). 763–774. 89 indexed citations
12.
Sehdev, Vikas, Mohammed Soutto, Abbes Belkhiri, Jeffrey Ecsedy, & Wael El‐Rifai. (2012). Effect of a combination of aurora kinase A inhibitor MLN-8237 and cisplatin on gastrointestinal tumors.. Journal of Clinical Oncology. 30(4_suppl). 58–58. 2 indexed citations
13.
Zhu, Shoumin, Jun Hong, Manish Tripathi, et al.. (2012). Regulation of CXCR4-Mediated Invasion by DARPP-32 in Gastric Cancer Cells. Molecular Cancer Research. 11(1). 86–94. 24 indexed citations
14.
Sehdev, Vikas, James C. K. Lai, & Alok Bhushan. (2009). Biochanin A Modulates Cell Viability, Invasion, and Growth Promoting Signaling Pathways in HER-2-Positive Breast Cancer Cells. Journal of Oncology. 2009. 1–10. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026